Cargando…
MuSyC dosing of adjuvanted cancer vaccines optimizes antitumor responses
With the clinical approval of T-cell–dependent immune checkpoint inhibitors for many cancers, therapeutic cancer vaccines have re-emerged as a promising immunotherapy. Cancer vaccines require the addition of immunostimulatory adjuvants to increase vaccine immunogenicity, and increasingly multiple ad...
Autores principales: | Taylor, David, Meyer, Christian T., Graves, Diana, Sen, Rupashree, Fu, Juan, Tran, Emily, Mirza, Bilal, Rodriguez, Gabriel, Lang, Cara, Feng, Hanwen, Quaranta, Vito, Wilson, John T., Kim, Young J., Korrer, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437625/ https://www.ncbi.nlm.nih.gov/pubmed/36059502 http://dx.doi.org/10.3389/fimmu.2022.936129 |
Ejemplares similares
-
MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery
por: Wooten, David J., et al.
Publicado: (2021) -
Music to prevent deliriUm during neuroSurgerY (MUSYC): a single-centre, prospective randomised controlled trial
por: Kappen, Pablo R, et al.
Publicado: (2023) -
Music to prevent deliriUm during neuroSurgerY (MUSYC) Clinical trial: a study protocol for a randomised controlled trial
por: Kappen, Pablo R, et al.
Publicado: (2021) -
Efferocytosis drives myeloid NLRP3 dependent inflammasome signaling secretion of IL-1β to promote tumor growth
por: Lang, Cara, et al.
Publicado: (2022) -
LHCb:MuSyC: a Software Package for the time alignment of the LHCb Muon System
por: Lai, A
Publicado: (2007)